BioSpace News Archive

BioCapital

Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19

AdCOVID, a Single-dose Intranasal Vaccine for COVID-19is Designed to Generate aBroad Immune Response Against COVID-19 with the Unique Ability to PromoteNasal Mucosal Immunity

November 10, 2020
·
10 min read
BioMidwest

Immunophotonics Announces First Patient Treated in Clinical Study Evaluating IP-001 in Patients with Advanced Solid Tumors

Immunophotonics, Inc. announces the first patient treated in the phase 1b/2a clinical trial examining IP-001 in thermally ablated solid tumors.

November 10, 2020
·
2 min read
Business

Photocure ASA: Results for the third quarter of 2020

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 49.6 million in the third quarter of 2020, with the U.S. market continuing the COVID-19 rebound with a growth of 20%.

November 10, 2020
·
5 min read
CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients

CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced the closing of its EUR50 million Series B financing round.

November 10, 2020
·
8 min read
BioCapital

Fina Biosolutions Announces European Patent for Conjugate Vaccine Development

Fina Biosolutions LLC (“FinaBio”) is pleased to announce that it has received a Certificate of Patent entitled “Expression and Purification of CRM Proteins and Related Proteins, and Protein Domains” from the European Patent Office (EPO).

November 10, 2020
·
3 min read
BioMidwest

JOMS study: Hoverboard head injuries more severe in adults

A new study finds head injuries involving hoverboards are more severe among adults; therefore, the researchers recommend helmet use to help prevent injuries.

November 10, 2020
·
4 min read
HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan for Development and Commercialisation in China

HitGen Inc. announces it has entered into a collaboration and licensing agreement with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd to develop and commercialise its HG030 programme in mainland China.

November 10, 2020
·
6 min read
Drug Development

Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City , is pleased to report interim results of the Phase 1 clinical trial of its plant-derived vaccine for COVID-19. The resu

November 10, 2020
·
4 min read
BioCapital

United Therapeutics Corporation To Present At The Jefferies Virtual London Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the Jefferies Virtual London Healthcare Confe

November 10, 2020
·
2 min read
Business

Activ Surgical Announces Formation of European Advisory Board

Activ Surgical ™, a digital surgery pioneer, today announced the formation of a European Advisory Board, further investing in its commitment to democratize surgical care and empower g

November 10, 2020
·
5 min read